Covariate selection in pharmacometric analyses: A review of methods

British Journal of Clinical Pharmacology

Volumn 79, Issue 1, 2015, Pages 132-147

  Hutmacher, Matthew M ^a   Kowalski, Kenneth G ^a  

^a ANN ARBOR PHARMACOMETRICS GROUP   (United States)

Author keywords

all subset regression; lasso; stepwise procedures; variable selection

Indexed keywords

ARTICLE; BAYES THEOREM; COVARIATE SELECTION; DRUG DOSE; GENETIC ALGORITHM; MAXIMUM LIKELIHOOD METHOD; NESTING; PHARMACOLOGY; PHARMACOMETRIC ANALYSIS; PREDICTOR VARIABLE; STATISTICAL ANALYSIS; ALGORITHM; BIOLOGICAL MODEL; COMPUTER SIMULATION; HUMAN; PHARMACOKINETICS; REGRESSION ANALYSIS;

ALGORITHMS; BAYES THEOREM; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; PHARMACOKINETICS; REGRESSION ANALYSIS;

EID: 85000154671     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12451     Document Type: Article

References (63)

1. Wiegand RE,. Performance of using multiple stepwise algorithms for variable selection. Stat Med 2010; 29: 1647-1659.
2. Efroymson MA,. Multiple regression analysis. In: Mathematical Method for Digital Computers, eds, Ralston A, Wilf HS,. New York: Wiley, 1960; 191-203.
3. Hamaker HC,. On multiple regression analysis. Stat Neerl 1962; 16: 31-56.
4. Boxenbaum H,. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm 1982; 10: 201-227.
5. Hoerl AE, Kennard RW,. Ridge regression: biased estimation for non-orthogonal problems. Technometrics 1970a; 12: 55-67.
6. Kendall MG,. A Course in Multivariate Analysis. New York, USA: Hafner Publishing Co, 1957.
7. Massy WF,. Principal components regression in exploratory statistical research. J Am Stat Assoc 1965; 560: 234-246.
8. Vonesh EF, Chinchilli VM,. Linear and Nonlinear Models for the Analysis of Repeated Measurements. New York, USA: Marcel Dekker Inc, 1997.
9. Ludden TM, Beal SL, Sheiner LB,. Comparison of the Akaike information criterion, the Schwarz criterion and the F test as guides to model selection. J Pharmacokinet Biopharm 1994; 29: 431-445.
10. Raftery AE, Madigan D, Hoeting JA,. Bayesian model averaging for linear regression models. J Am Stat Assoc 1997; 92: 179-191.
11. Hjort NL, Claeskens G,. Frequentist model average estimators. J Am Stat Assoc 2003; 98: 879-899.
12. Kowalski KG, Hutmacher MM,. Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study. Stat Med 2001a; 20: 75-91.
13. Wade JR, Beal SL, Sambol NC,. Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis. J Pharmacokinet Biopharm 1994; 22: 165-177.
14. Hocking RR,. The analysis and selection of variables in linear regression. Biometrics 1976; 32: 1-49.
15. Harrell FE Jr,. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, USA: Springer, 2001.
16. Derksen S, Keselman HJ,. Backward, forward and stepwise automated subset selection algorithms: frequency of obtaining authentic and noise variables. Br J Math Stat Psychol 1992; 45: 265-282.
17. Hoerl AE, Kennard RW,. Ridge regression: applications to non-orthogonal problems. Technometrics 1970b; 12: 69-82.
18. Hutmacher MM, Nestorov I, Ludden T, Zitnik R, Banfield C,. Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis. J Clin Pharmacol 2007; 47: 238-248.
19. Efron B, Hinkley DV,. Assessing the accuracy of the maximum likelihood estimator: observed versus expected fisher information. Biometrika 1978; 65: 457-487.
20. Efron B,. Nonparametric standard errors and confidence intervals. Can J Stat 1981; 9: 139-172.
21. Freedman DA,. A note on screening regression equations. Am Stat 1983; 37: 152-155.
22. Cox DR, Hinkley DV,. Theoretical Statistics. New York, USA: Chapman and Hall, 1974.
23. Beal SL, Sheiner LB, Boeckmann AJ, eds. NONMEM Users Guides. Ellicott City, USA: Icon Development Solutions, 1989-2006.
24. Vonesh EF,. A note on the use of Laplace's approximation for nonlinear mixed-effects models. Biometrika 1996; 83: 447-452.
25. Wählby U, Jonsson EN, Karlsson MO,. Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn 2001; 28: 231-252.
26. Beal SL,. Commentary on significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn 2002; 29: 403-410; discussion 411-412.
27. Akaike H,. A new look at the statistical model identification. IEEE Trans Automatic Control 1974; 19: 716-723.
28. Hurvich CM, Tsai CL,. Regression and time series model selection in small samples. Biometrika 1989; 76: 297-307.
29. Schwarz G,. Estimating the dimension of a model. Ann Stat 1978; 6: 461-465.
30. Jones RH,. Bayesian information criterion for longitudinal and clustered data. Stat Med 2011; 30: 3050-3056.
31. Clayton MK, Geisser S, Jennings DE,. A comparison of several model selection procedures. In: Studies in Bayesian Econometrics and Statistics, eds, Goel PL, Zellner A,. New York, USA: Elsevier, 1986; 425-439.
32. Laud PW, Ibrahim JG,. Predictive model selection. J R Stat Soc B 1995; 57: 247-262.
33. Montgomery DC, Peck EA,. Introduction to Linear Regression Analysis. New York, USA: John Wiley and Sons, Inc, 1982.
34. Mantel N,. Why stepdown procedures in variable selection. Technometrics 1970; 15: 661-675.
35. Draper NR, Smith H,. Applied Regression Analysis. New York: John Wiley and Sons, Inc, 1981.
36. Mandema JW, Verotta D, Sheiner LB,. Building population pharmacokinetic-pharmacodynamic models. I. models for covariate effects. J Pharmacokinet Biopharm 1992; 20: 511-528.
37. Hastie T, Tibshirani R,. Generalized additive models. Stat Sci 1986; 3: 297-310.
38. Savic RM, Karlsson MO,. Importance of shrinkage in empirical Bayes estimates for diagnostics: problems and solutions. AAPS J 2009; 11: 558-569.
39. Jonsson EN, Karlsson MO,. Automated covariate model building within NONMEM. Pharm Res 1998; 15: 1463-1468.
40. Khandelwal A, Harling K, Jonsson EN, Hooker AC, Karlsson MO,. A fast method for testing covariates in population PK/PD Models. AAPS J 2011; 13: 464-472.
41. Leon-Novelo L, Moreno E, Casella G,. Objective Bayes model selection in probit models. Statist Med 2012; 31: 353-365.
42. Garside MJ,. The best subset in multiple regression analysis. J R Stat Soc Ser C Appl Stat 1965; 14: 196-200.
43. Furnival GM,. All possible regressions with less computation. Technometrics 1971; 13: 403-408.
44. Goodnight JH,. A tutorial on the SWEEP operator. Am Stat 1979; 33: 149-158.
45. Hocking RR, Leslie RN,. Selection of the best subset in regression analysis. Technometrics 1967; 9: 531-540.
46. Furnival GM, Wilson RW Jr,. Regression by leaps and bounds. Technometrics 1974; 16: 499-511.
47. Lawless JF, Singhal K,. Efficient screening of nonnormal regression models. Biometrics 1978; 34: 318-327.
48. Kowalski KG, Hutmacher MM,. Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio test. J Pharmacokinet Pharmacodyn 2001b; 28: 253-275.
49. Wald A,. Tests of statistical hypotheses concerning several parameters when the number of observations is large. Trans Am Math Soc 1943; 54: 426-482.
50. Bies RR, Muldoon MF, Pollock BG, Manuck S, Smith G, Sale ME,. A genetic algorithm-based, hybrid machine learning approach to model selection. J Pharmacokinet Pharmacodyn 2006; 33: 195-221.
51. Sherer EA, Sale ME, Pollock BG, Belani CP, Egorin MJ, Ivy PS, Lieberman JA, Manuck SB, Marder SR, Muldoon MF, Scher HI, Solit DB, Bies RR,. Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building. J Pharmacokinet Pharmacodyn 2012; 39: 393-414.
52. Tibshirani R,. Regression shrinkage and selection via the lasso. J R Stat Soc B 1996; 58: 267-288.
53. Ribbing J, Nyberg J, Caster O, Jonsson EN,. The lasso-a novel method for predictive covariate model building in nonlinear mixed effects models. J Pharmacokinet Pharmacodyn 2007; 34: 485-517.
54. Tibshirani R,. The lasso method for variable selection in the Cox model. Stat Med 1997; 16: 385-395.
55. Fan J, Li R,. Variable selection via nonconcave penalized likelihood and its oracle properties. J Am Stat Assoc 2001; 96: 1348-1360.
56. Lunn DJ,. Automated covariate selection and Bayesian model averaging in population PK/PD models. J Pharmacokinet Pharmacodyn 2008; 35: 85-100.
57. Breiman L, Spector P,. Submodel selection and evaluation in regression-the X-random case. Int Stat Rev 1992; 60: 291-319.
58. Sauerbrei W, Schumacher M,. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med 1992; 11: 2093-2109.
59. Shao J,. Bootstrap model selection. J Am Stat Assoc 1996; 91: 655-665.
60. Cohen J,. Things I have learned (so far). Am Psychol 1990; 45: 1304-1312.
61. Gastonguay M,. Full covariate models as an alternative to methods relying on statistical significance for inferences about covariate effects: a review of methodology and 42 case studies. PAGE 20, Abstr 2229. 2011. Available at http://www.page-meeting.org/?abstract=2229 (last accessed 16 July 2014).
62. Hu C, Zhang J, Zhou H,. Confirmatory analysis for phase III population pharmacokinetics. Pharm Stat 2011; 10: 14-26.
63. Steyerberg EW, Eijkemans MJC, Habbema JDF,. Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 1999; 52: 935-942.